The Patent Finder
AC

AstraZeneca Computational Pathology GmbH

First filing 2018
OverviewNotableFeesChangesPatent listSources & methods

Two patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Oct 2041. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Oct 2041
Next term end
2
Patent families

When these terms end

Each bar runs from grant to computed term end. 2023 to 2042.
US 11,593,656 Using a First Stain to Train a Model to Predict the Region Stained by a Second Stain Oct 8, 2041
US 11,651,863 Predicting Prostate Cancer Recurrence Using a Prognostic Model that Combines Immunohistochemical Staining and Gene Expression Profiling Feb 3, 2042
20272031203520392042
Every computed term in this portfolio is shown above.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Patents held now

Soonest term end first.

Showing 1 to 2 of 2

PatentTitleStatusExpiresConfidence
US 11,593,656Using a First Stain to Train a Model to Predict the Region Stained by a Second Stain
In force
 · High confidence
In forceHigh confidence
US 11,651,863Predicting Prostate Cancer Recurrence Using a Prognostic Model that Combines Immunohistochemical Staining and Gene Expression Profiling
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited